Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ABTX - Agribiotech -- Ignore unavailable to you. Want to Upgrade?

To: Mr. Miller who wrote (1296)	12/12/1997 11:38:00 PM
From: InvestorLady	Read Replies (2) \| Respond to of 8359

ABTX, in the normal action of a stock, is overdue for a pull back---any body who follows TA and has been in the markets a while would generally agree to this. But ABTX has not been acting normal. It has incredible buying strength in the face of a tenuous market. I wonder what it would be doing in a strong market? It has a consistent history of casually going into the next point level, creating new highs on so so volume. There are two major firms, Nat West and Merrill Lynch, that cover the seed sector that may join Solomon in initiating coverage as they sort of need to, to be in step. There is something like 11-12 firms that cover this sector. We have only heard from a few to date. Now if a biotech deal is as close as we have been hearing this may cause heated up buying from institutional folks who don't want to miss the ride. Look at the size blocks this past week, some big trades getting in. Remember, the stock is now over the $15 threshold which is a magic number to allow even the more conservative funds to get in. Looking at the chart, ABTX has just caught up to where it SHOULD have been if the crash hadn't interferred with the path. The way I see it (and I could of course be wrong) is that the same spike distance down could very likely happen to the upside, which puts the stock at $18-19 to balance out the chart on its upward path. While this move seems vertical, in essence, it has just been playing catch up to get back on track and is not really over-extended, yet, given the path. (Draw a trend line and extend out into January/February across the highs and lows prior to the crash.) While many I know agree with Lucky that it is due for a pull back, this stock has fooled people before. I plan to do some hedging myself when the time is right, but not at $16. BTW, there is no resisitance at $16---should we go through $15 3/4 with volume, it could run more. IMHO this stock is STILL undervalued at these levels and doesn't even begin to approach fair value (IMHO) until $25 or so, assuming a biotech deal is around the corner. And even that could get taken out with more acquisitions. Remember, at least two are closing near or soon after Jan. 1, 1998. That is not too far away. The stock is now reacting to news and has attracted momentum players as well. Now, just how much does JT look like Santa Claus these days? If a biotech deal is announced next week, which apparently is the earliest it could be, my guess is the shorts could contribute to a bit of a short squeeze with momentum and institutional players contributing to panic buying as my friend Bill calls it. Hey, there are many ways to play the market. But the risk reward of shorting at this level seems not worth it when next week could potentially be another newsworthy week (IMHO). IF it is quiet, the mms will slam it as they probably have had to average up along the way. (It looks like they may have tried this Friday, but the stock held strong above $15.) Awfully big IF, IMHO. Good luck to all. Sometimes that is all you have when you don't really understand a stock. Even when you do, luck still plays a factor as we don't know the future for certain. :-) Anette

To: Mr. Miller who wrote (1296)	12/13/1997 12:05:00 AM
From: maaad	Respond to of 8359

Miller, Great call! Got anymore? From BCMD Thread............... exchange2000.com Up +20% in three days<GGG>!!

To: Mr. Miller who wrote (1296)	12/13/1997 4:05:00 AM
From: glen	Read Replies (2) \| Respond to of 8359

TM Miller, You are hereby THWAPPED!!I cannot believe you are still hung up on market share. I tried to explain to you using the Blockbuster example that the key is to build a distribution system, not necessarily a monopoly. The real growth of ABTX will be when JT can develop his product mix and feed it through the pipeline that he is now in the process of building. Once he reaches 50% market, it's 20-30% internal growth that will make ABTX a giant. Sure, JT will continue to increase sales above the $500 million sales mark, but it will no longer be the #1 priority. Miller, do you really need this spoon fed to you? The first 1/2 billion is the key to the candy store. Once JT's inside, his #1 priority is to go after all the goodies. If he picks up a few spare keys along the way(i.e. increased sales), that's ok. So, stop being so hung up on market share..it's just the trojan horse. Miller, do you read with your eyes closed. You asked "how will they get above $700, if they want to do that?" Who, besides you, ever said that was their desired goal? Did you read what Pete and I had to report from JT's presentation at the DAIN CONFERENCE. If so, did it go in one ear and out the other? This is the last time I will attempt to say it. JT's #1 priority is to reach 500+ million in sales before December 1998. From 1998 till ad infinitum, the #1 goal is to have an internal growth rate of 20-30% annualized, (via high profit margined product mix and genetic/biotech enhancements). It's the latter goal, not the former, in which lies the true riches and growth for ABTX's future success. Just as WH did not have to own every single video store when he built Blockbuster to be a giant, JT will not need every distributor either, nor even close to every one. You are still thwapped for making me repeat once again, JT's plans for ABTX. regards, TM glen